ARTICLE | Company News
France to reimburse off-label Avastin for AMD
August 28, 2015 11:10 PM UTC
France's Minister of Social Affairs and Health approved reimbursement for the off-label use of Avastin bevacizumab to treat age-related macular degeneration (AMD).
In June, the French National Agency for Medicines and Health Products Safety (ANSM) issued a temporary recommendation for use (RTU) for Avastin in AMD. Both the reimbursement and RTU will take effect Sept. 1. ...